CCND1 and prostate adenocarcinoma: Analyzing by immunohistochemistry of the localization of Cyclin D1 in endometrial, breast, prostate, and colon carcinomas with different types of invasion, Fustè et al. [89] found that in prostatic adenocarcinoma Cyclin D1 displays an asymmetric pattern of localization.